- Bateman, Daniel;
- Gill, Sascha;
- Hu, Sophie;
- Foster, Erin;
- Ruthirakuhan, Myuri;
- Sellek, Allis;
- Mortby, Moyra;
- Matušková, Veronika;
- Ng, Kok;
- Tarawneh, Rawan;
- Freund-Levi, Yvonne;
- Kumar, Sanjeev;
- Gauthier, Serge;
- Rosenberg, Paul;
- Ferreira de Oliveira, Fabricio;
- Devanand, D;
- Ballard, Clive;
- Ismail, Zahinoor
To identify knowledge gaps regarding new-onset agitation and impulsivity prior to onset of cognitive impairment or dementia the International Society to Advance Alzheimers Research and Treatment Neuropsychiatric Syndromes (NPS) Professional Interest Area conducted a scoping review. Extending a series of reviews exploring the pre-dementia risk syndrome Mild Behavioral Impairment (MBI), we focused on late-onset agitation and impulsivity (the MBI impulse dyscontrol domain) and risk of incident cognitive decline and dementia. This scoping review of agitation and impulsivity pre-dementia syndromes summarizes the current biomedical literature in terms of epidemiology, diagnosis and measurement, neurobiology, neuroimaging, biomarkers, course and prognosis, treatment, and ongoing clinical trials. Validations for pre-dementia scales such as the MBI Checklist, and incorporation into longitudinal and intervention trials, are needed to better understand impulse dyscontrol as a risk factor for mild cognitive impairment and dementia.